243 related articles for article (PubMed ID: 36780463)
1. Hippo signaling and histone methylation control cardiomyocyte cell cycle re-entry through distinct transcriptional pathways.
Zhang Z; Freeman M; Zhang Y; El-Nachef D; Davenport G; Williams A; MacLellan WR
PLoS One; 2023; 18(2):e0281610. PubMed ID: 36780463
[TBL] [Abstract][Full Text] [Related]
2. Repressive histone methylation regulates cardiac myocyte cell cycle exit.
El-Nachef D; Oyama K; Wu YY; Freeman M; Zhang Y; MacLellan WR
J Mol Cell Cardiol; 2018 Aug; 121():1-12. PubMed ID: 29800554
[TBL] [Abstract][Full Text] [Related]
3. H3K9me3 demethylase Kdm4d facilitates the formation of pre-initiative complex and regulates DNA replication.
Wu R; Wang Z; Zhang H; Gan H; Zhang Z
Nucleic Acids Res; 2017 Jan; 45(1):169-180. PubMed ID: 27679476
[TBL] [Abstract][Full Text] [Related]
4. The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway.
Dong F; Jiang S; Li J; Wang Y; Zhu L; Huang Y; Jiang X; Hu X; Zhou Q; Zhang Z; Bao Z
EBioMedicine; 2019 Jan; 39():472-483. PubMed ID: 30527625
[TBL] [Abstract][Full Text] [Related]
5. The testis-enriched histone demethylase, KDM4D, regulates methylation of histone H3 lysine 9 during spermatogenesis in the mouse but is dispensable for fertility.
Iwamori N; Zhao M; Meistrich ML; Matzuk MM
Biol Reprod; 2011 Jun; 84(6):1225-34. PubMed ID: 21293030
[TBL] [Abstract][Full Text] [Related]
6. RNA-dependent chromatin localization of KDM4D lysine demethylase promotes H3K9me3 demethylation.
Zoabi M; Nadar-Ponniah PT; Khoury-Haddad H; Usaj M; Budowski-Tal I; Haran T; Henn A; Mandel-Gutfreund Y; Ayoub N
Nucleic Acids Res; 2014 Dec; 42(21):13026-38. PubMed ID: 25378304
[TBL] [Abstract][Full Text] [Related]
7. Histone demethylase KDM4D cooperates with NFIB and MLL1 complex to regulate adipogenic differentiation of C3H10T1/2 mesenchymal stem cells.
Choi JH; Lee H
Sci Rep; 2020 Feb; 10(1):3050. PubMed ID: 32080306
[TBL] [Abstract][Full Text] [Related]
8. Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.
Ikeda S; Mizushima W; Sciarretta S; Abdellatif M; Zhai P; Mukai R; Fefelova N; Oka SI; Nakamura M; Del Re DP; Farrance I; Park JY; Tian B; Xie LH; Kumar M; Hsu CP; Sadayappan S; Shimokawa H; Lim DS; Sadoshima J
Circ Res; 2019 Jan; 124(2):292-305. PubMed ID: 30582455
[TBL] [Abstract][Full Text] [Related]
9. Hippo pathway effector Yap promotes cardiac regeneration.
Xin M; Kim Y; Sutherland LB; Murakami M; Qi X; McAnally J; Porrello ER; Mahmoud AI; Tan W; Shelton JM; Richardson JA; Sadek HA; Bassel-Duby R; Olson EN
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13839-44. PubMed ID: 23918388
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E
Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
[TBL] [Abstract][Full Text] [Related]
11. RHOA activity in expanding blastocysts is essential to regulate HIPPO-YAP signaling and to maintain the trophectoderm-specific gene expression program in a ROCK/actin filament-independent manner.
Marikawa Y; Alarcon VB
Mol Hum Reprod; 2019 Feb; 25(2):43-60. PubMed ID: 30395288
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
13. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
[TBL] [Abstract][Full Text] [Related]
14. Melatonin promotes cardiomyocyte proliferation and heart repair in mice with myocardial infarction via miR-143-3p/Yap/Ctnnd1 signaling pathway.
Ma WY; Song RJ; Xu BB; Xu Y; Wang XX; Sun HY; Li SN; Liu SZ; Yu MX; Yang F; Ye DY; Gong R; Han ZB; Yu Y; Bamba D; Wang N; Pan ZW; Cai BZ
Acta Pharmacol Sin; 2021 Jun; 42(6):921-931. PubMed ID: 32839503
[TBL] [Abstract][Full Text] [Related]
15. Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling.
Hu F; Li H; Liu L; Xu F; Lai S; Luo X; Hu J; Yang X
Mol Cancer; 2018 Jul; 17(1):107. PubMed ID: 30060750
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway.
Zhu G; Wang Y; Mijiti M; Wang Z; Wu PF; Jiafu D
Biochem Biophys Res Commun; 2015 Sep; 465(2):194-9. PubMed ID: 26241672
[TBL] [Abstract][Full Text] [Related]
17. Importance of the filamin A-Sav1 interaction in organ size control: evidence from transgenic mice.
Zhang H; Yang Z; Nakamura F
Int J Dev Biol; 2023; 67(2):27-37. PubMed ID: 37548015
[TBL] [Abstract][Full Text] [Related]
18. TRIM14 inhibits OPTN-mediated autophagic degradation of KDM4D to epigenetically regulate inflammation.
Liu D; Zhao Z; She Y; Zhang L; Chen X; Ma L; Cui J
Proc Natl Acad Sci U S A; 2022 Feb; 119(7):. PubMed ID: 35145029
[TBL] [Abstract][Full Text] [Related]
19. Control of enhancer and promoter activation in the type I interferon response by the histone demethylase Kdm4d/JMJD2d.
Chandwani R; Fang TC; Dewell S; Tarakhovsky A
Front Immunol; 2023; 14():1146699. PubMed ID: 37275914
[TBL] [Abstract][Full Text] [Related]
20. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
